Let’s get phygital 2021: transforming from biotech to biopharma
Transforming from biotech to biopharma: creating a new value chain to serve unmet patient needs.
Discover how Galapagos’ supply chain acted as the backbone of their transformation from a biotech to a biopharma company.
By Wouter Keymeulen, VP Quality Galapagos, and Pieter Van den Meutter, Head of Customer Intelligence Bluecrux.